Viatris Names A Trio Of Complex Injectable Targets Amid Teva Symbicort Interest

Potential For Several Launches In 2025; Key FDA Meeting For GA Depot Before Year-End

 
• By Dean Rudge
  
business arrow target direction concept to success. Finance growth vector
• Source: Shutterstock

More from Earnings

More from Generics Bulletin